Organization
Leiden University Medical Centre, Leiden, Netherlands
6 abstracts
Abstract
5-YEAR FOLLOW-UP OF A NORWEGIAN COHORT OF PATIENTS WITH ANKYLOSING SPONDYLITIS: EVALUATION OF THE DISCRIMINATORY CAPACITY OF ASDAS AND BASDAI BETWEEN PATIENTS WITH WORSE VERSUS IMPROVED HEALTH OVER 5 YEARS Org: Dept of Rheumatology, Diakonhjemmet Hospital, Oslo, Norway, Leiden University Medical Centre, Leiden, Netherlands,
Abstract
ANTI-TNF-ALPHA BLOCKING AGENTS IN JUVENILE PSORIATIC ARTHRITIS; IS IT EFFECTIVE? Org: Erasmus MC Sophia Children's Hospital, Rotterdam, Leiden University Medical Centre, Leiden, Netherlands, Academic Medical Centre Emma Children's Hospital and Jan van Breemen Institute, Amsterdam, Utrecht MC Wilhelmina Children's Hospital, Utrecht, Radboud University Nijmegen Medical Centre, Nijmegen, Netherlands,
Abstract
ACHIEVEMENT OF PASDAS LOW DISEASE ACTIVITY AND VERY LOW DISEASE ACTIVITY IN PATIENTS WITH PSORIATIC ARTHRITIS TREATED WITH CERTOLIZUMAB PEGOL OVER 4 YEARS AND THE OVERLAP WITH DAPSA AND MDA DISEASE ACTIVITY TARGETSOrg: Nuffield Orthopaedic Centre, Oxford, United Kingdom, Brigham and Women’s Hospital, Harvard Medical School, Boston, MA, United States of america, St Vincent’s University Hospital and Conway institute for Biomolecular Research, University College Dublin, Dublin, Ireland, Division of Rheumatology allergy and Immunology, UC San Diego School of Medicine, La Jolla, CA, United States of america, Department of Dermatology, ICahn School of Medicine at Mt Sinai, New York, NY, United States of america,
Abstract
AN IMPROVED MATRIX TO PREDICT RAPID RADIOGRAPHIC PROGRESSION OF EARLY RHEUMATOID ARTHRITIS PATIENTS: POOLED ANALYSES FROM SEVERAL DATABASES Org: UPMC Univ Paris 6 and AP-HP Pitié-Salpêtrière Hospital, Paris, France, University of Vienna, Vienna, Austria, Leiden University Medical Centre, Leiden, Netherlands, Karolinska Institute, Stockholm, Sweden, Leuven University, Leuven, Belgium,
Abstract
ASSOCIATION BETWEEN CLINICAL AND RADIOGRAPHIC RESPONSES, AND PHYSICAL FUNCTION IN A PHASE 3 STUDY OF SARILUMAB PLUS METHOTREXATE IN PATIENTS WITH ACTIVE, MODERATE-TO-SEVERE RHEUMATOID ARTHRITIS Org: Stanford University Medical Center, Palo Alto, CA, Sanofi Genzyme, Bridgewater, Regeneron Pharmaceuticals, Inc., Tarrytown, United States, Leiden University Medical Centre, Leiden, Netherlands,
Abstract
BASELINE PARAMETERS IDENTIFIED IN EARLY, METHOTREXATE-NAÏVE RHEUMATOID ARTHRITIS PATIENTS WITH BETTER OUTCOMES WITH CERTOLIZUMAB PEGOL+METHOTREXATE COMPARED TO PLACEBO+METHOTREXATE: POST-HOC ANALYSES OF C-OPERA, A RANDOMIZED, CONTROLLED, PHASE 3 SOrg: Hokkaido University Graduate School of Medicine, Hokkaido, The University of Tokyo, Tokyo, Japan, Keio University School of Medicine, Tokyo Women's Medical University, Tokyo, Japan, Nagoya University, Nagoya,